Medicare Enrolled
Dr. John Kaspar, M.D.
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician · Raleigh, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kaspar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kaspar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kaspar
Dr. John Kaspar is an urogynecology and reconstructive pelvic surgery physician in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kaspar performed 15,840 Medicare services across 3,090 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kaspar received a total of $1,126,931 from 53 pharmaceutical and/or device companies across 1795 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urogynecology and reconstructive pelvic surgery (urology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kaspar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 25% volume in NC
$1,126,931 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,840
Medicare services
Top 25% in NC for urogynecology and reconstructive pelvic surgery (urology) physician
3,090
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~792 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
8,200 | $5 | $18 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,200 | $0 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
830 | $90 | $209 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
758 | $5 | $19 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
499 | $7 | $35 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
424 | $2 | $8 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
377 | $3 | $12 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
187 | $157 | $479 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
182 | $659 | $2,757 |
| PSA test (prostate cancer screening) | 173 | $18 | $68 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
125 | $109 | $308 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $57 | $124 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
76 | $104 | $279 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
66 | $41 | $168 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
64 | $25 | $96 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
52 | $11 | $59 |
| Injection, garamycin, gentamicin, up to 80 mg | 51 | $2 | $5 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
48 | $277 | $908 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
43 | $23 | $375 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
41 | $147 | $328 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
40 | $5 | $100 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
36 | $961 | $3,605 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
35 | $197 | $876 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
35 | $5 | $19 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
34 | $270 | $600 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
26 | $54 | $219 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
25 | $25 | $88 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
24 | $282 | $988 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
23 | $16 | $35 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
21 | $15 | $51 |
| Insertion of peripheral or gastric neurostimulator generator A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach. |
16 | $103 | $770 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $28 | $75 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $170 | $723 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
76.9% medium
22.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,126,931
Total received (2018-2024)
Avg $160,990/year across 7 years
Top 17% in NC for urogynecology and reconstructive pelvic surgery (urology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,795
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$956,678 (84.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$154,765 (13.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,489 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$73,520
2023
$173,146
2022
$247,480
2021
$217,547
2020
$155,283
2019
$173,549
2018
$86,407
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$70,801
Dendreon Pharmaceuticals LLC
$1,590
Axonics, Inc.
$406
Sumitomo Pharma America, Inc.
$232
ABBVIE INC.
$88
PROCEPT BioRobotics Corporation
$87
Myriad Genetic Laboratories, Inc.
$43
UROGEN PHARMA, INC.
$39
Endo USA, Inc.
$39
Blue Earth Diagnostics Limited
$38
Merck Sharp & Dohme LLC
$32
Laborie Medical Technologies Corp.
$28
PROGENICS PHARMACEUTICALS, INC.
$24
Janssen Biotech, Inc.
$22
PFIZER INC.
$20
Novo Nordisk Inc
$17
Antares Pharma, Inc.
$14
Top 3 companies account for 99.0% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$706,056
NeoTract Inc.
$383,125
Astellas Pharma US Inc
$12,804
Axonics, Inc.
$7,117
Dendreon Pharmaceuticals LLC
$5,566
SRS Medical Systems, Inc.
$2,776
Olympus America Inc.
$2,294
PROCEPT BioRobotics Corporation
$975
Axonics Modulation Technologies, Inc.
$947
Olympus Corporation of the Americas
$648
Janssen Biotech, Inc.
$494
Myriad Genetic Laboratories, Inc.
$390
Sumitomo Pharma America, Inc.
$363
Blue Earth Diagnostics Limited
$315
ABBVIE INC.
$298
Accord Healthcare, Inc.
$238
Endo Pharmaceuticals Inc.
$226
UROVANT SCIENCES INC
$224
Antares Pharma, Inc.
$159
Valencia Technologies Corporation
$157
Allergan, Inc.
$151
Avadel Specialty Pharmaceuticals, LLC
$136
Ferring Pharmaceuticals Inc.
$129
Amgen Inc.
$123
Medtronic USA, Inc.
$103
TOLMAR Pharmaceuticals, Inc.
$100
Bayer HealthCare Pharmaceuticals Inc.
$92
Acerus Pharmaceuticals Corporation
$85
UroGen Pharma, Inc.
$85
PFIZER INC.
$84
Allergan Inc.
$83
UROGEN PHARMA, INC.
$55
Merck Sharp & Dohme LLC
$47
Arrow International, Inc.
$47
Clarus Therapeutics Inc.
$43
Endo USA, Inc.
$39
Travere Therapeutics, Inc.
$33
Myovant Sciences Inc.
$32
Laborie Medical Technologies Corp.
$28
Tolmar, Inc.
$27
AbbVie Inc.
$27
Mission Pharmacal Company
$25
Ambu Inc.
$25
PROGENICS PHARMACEUTICALS, INC.
$24
Baxter Healthcare
$20
Supernus Pharmaceuticals, Inc.
$18
Baudax Bio Inc.
$18
Novo Nordisk Inc
$17
Telix Pharmaceuticals
$16
COLOPLAST CORP
$14
Boston Scientific Corporation
$12
AbbVie, Inc.
$11
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 97.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ANJESO · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACAnalysis CDx · Bulkamid · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL KIDNEY STONE DISEASE · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · OES CYSTONEPHROFIBERSCOPE · ORGOVYX · OTREXUP · Olympus Laser Devices · Optilume BPH Drug Coated Balloon Catheter · Otrexup · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · Rivfloza · SUTENT · TESTOPEL · TISSEEL · TOVIAZ · Thiola · URIBEL · UROLIFT · UROLIFT ATC SYSTEM · UROLIFT SYSTEM · UroCuff · UroLift · UroLift 2 System · UroLift ATC System · UroLift System · Urocit-K · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urogynecology and reconstructive pelvic surgery (urology) physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Urogynecology and reconstructive pelvic surgery physicians within 10 mi
2
Per 100K population
0.2
County median income
$101,763
Nearest hospital
REX HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kaspar is a mixed practice specialist, with above-average Medicare volume (top 25% in NC), with speaking/promotional industry engagement in the top 17% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kaspar experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Kaspar performed 8,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kaspar receive payments from pharmaceutical companies?
Yes. Dr. Kaspar received a total of $1,126,931 from 53 companies across 1,795 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kaspar's costs compare to other urogynecology and reconstructive pelvic surgery physicians in Raleigh?
Dr. Kaspar's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kaspar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urogynecology And Reconstructive Pelvic Surgery Physicians in Raleigh
Browse urogynecology and reconstructive pelvic surgery physicians in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Urogynecology And Reconstructive Pelvic Surgery Physicians in NC
Urogynecology and reconstructive pelvic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urogynecology And Reconstructive Pelvic Surgery Physicians in NC
Which NC urogynecology and reconstructive pelvic surgery physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology